Mr. Dieter A. Enkelmann is a Chief Financial Officer at Bank Julius Bär & Co. AG, at Julius Bär Gruppe AG, an Independent Non-Executive Director at Cosmo Pharmaceuticals NV, and a Chairman-Foundation Board at Stiftung Für Angewandte Krebsforschung.

He is on the Board of Directors at Cosmo Pharmaceuticals NV.

From 2003 until 2006 he was the Chief Financial Officer of Barry Callebaut AG, the world's leading manufacturer of high-quality cocoa, chocolate and confectionery products which is listed on the SWX. From 1997 to 2003 he was at Swiss Re as Head of Finance of the Business Unit Financial Services and as Head of Corporate Finance and Investor Relations, Treasury. From 1985 to 1997 he was at Credit Suisse First Boston.

Mr. Enkelmann holds a law diploma from the University of Zürich.